897 reports of this reaction
4.4% of all LANREOTIDE ACETATE reports
#4 most reported adverse reaction
FATIGUE is the #4 most commonly reported adverse reaction for LANREOTIDE ACETATE, manufactured by Ipsen Biopharmaceuticals, Inc.. There are 897 FDA adverse event reports linking LANREOTIDE ACETATE to FATIGUE. This represents approximately 4.4% of all 20,256 adverse event reports for this drug.
Patients taking LANREOTIDE ACETATE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among LANREOTIDE ACETATE users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for LANREOTIDE ACETATE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 897 FDA reports for LANREOTIDE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 4.4% of all adverse event reports for LANREOTIDE ACETATE, making it a notable side effect.
If you experience fatigue while taking LANREOTIDE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.